RxDoctor Payments DataLook up a doctor →

Ryan Hill-Falkenthal, PA

Surgical · Goodyear, AZNPI 1437780665

Payments from drug & device makers

$52,584in general payments, 2019–2025

Across 537 payments — averaging $97.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik NRO, Inc.$15K
  • Spinal Simplicity, LLC$11K
  • Abbott$6K
  • Nevro Corp.$3K
  • Saluda Medical Americas, Inc.$3K
  • Medtronic$2K
  • plus $11K from 24 others

What the payments were for

  • Consulting fees$4,8259%
  • Speaking & faculty fees$10,99421%
  • Travel & lodging$12,31723%
  • Food & beverage$22,64843%
  • Education$1,8003%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,584 in reported general payments places this provider in the 95th percentile of 271 surgical providers in Arizona.

See all surgical providers in Arizona

Medicare billing

Part B allowed, 2024
$26,688
Medicare patients
168
Services billed
1,510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate51$18,542
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen647$17,602
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen608$10,331
Buprenorphine20$5,734
MovantikNaloxegol Oxalate13$5,147
Gabapentin240$3,873
Morphine Sulfate ErMorphine Sulfate123$2,967
Fentanyl20$2,932
Oxycodone Hcl139$2,608
Tramadol Hcl369$1,890
Pregabalin42$1,326
Morphine Sulfate43$1,184
Tizanidine Hcl101$1,023
Methocarbamol66$855
Duloxetine Hcl26$707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$230$18,54251 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 271 surgical providers in Arizona.

Other surgical in Goodyear

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →